[Driver gene mutations predicted by pathology-foundation-model and their clinical associations in clear cell renal cell carcinoma] [0.03%]
病理特征预测的驱动基因变异及其临床意义在透明细胞肾癌中的相关性研究
S Y Tan,Y Y Zhang,W Chen et al.
S Y Tan et al.
Objective: To evaluate the performance of a deep learning framework based on the PathOrchestra pathology foundation model for predicting key driver gene mutations (VHL, PBRM1, BAP1, and SETD2) in clear cell renal cell carcinoma (ccRCC), and...
[Mesenchymal tumors with GLI1 gene alterations: a clinicopathological analysis of five cases] [0.03%]
GLI1基因异常的间叶源性肿瘤：5例临床病理分析
X G Liu,Y Wang,Y K Lyu et al.
X G Liu et al.
Objective: To investigate the clinicopathological and genetic characteristics of mesenchymal tumors with GLI1 gene alterations. Methods: Five cases diagnosed at the Tongji Hospital, Tongji Medical College, Huazhong University of Science and...
[Erdheim-Chester disease: a clinicopathological analysis of 16 cases] [0.03%]
Erdheim-Chester病的临床病理特征及总结-附16例分析
L Zhang,H Z Zhang,Y L Luo et al.
L Zhang et al.
Objective: To investigate the clinicopathological features, diagnosis, and prognosis of Erdheim-Chester disease. Methods: The clinical and imaging data of 16 patients with Erdheim-Chester disease diagnosed in the Department of Pathology, Sh...
[Detection of DDIT3 gene rearrangement in myxoid liposarcoma using fluorescence in situ hybridization: its clinical application and cryptic signals] [0.03%]
荧光原位杂交检测DDIT3基因重排及其在黏液样脂肪肉瘤的临床应用和隐匿信号分析
M Chen,W Y Jing,X He et al.
M Chen et al.
Objective: To investigate the clinical application of DDIT3 gene rearrangement using fluorescence in situ hybridization (FISH) in myxoid liposarcoma (MLPS) and to analyze the cases with atypical signal pattern. Methods: A total of 386 cases...
[Interpretation of the 2025 edition ISSVA new classification of vascular anomalies] [0.03%]
2025年ISSVA血管异常新分类解读
S Li,Q Y Liu
S Li
In conjunction with the new 2025 ISSVA classification, this article interprets the classification of this group of diseases one by one and elaborates on clinical and pathological issues related to the new classification. It aims to provide ...
[The interpretation of pathological content in the 2025 ERS/ATS international multidisciplinary classification of interstitial pneumonia] [0.03%]
[2025年ERS/ATS间质性肺炎国际多学科分类中病理内容的解读]
H K Xie,C Y Wu
H K Xie
In August 2025, an updated International Multidisciplinary Classification of Interstitial Pneumonias was released by the European Respiratory Society (ERS) and American Thoracic Society (ATS). For the first time, the "idiopathic-only" parad...
[Solid pseudopapillary tumor of the pancreas combined with serous cystadenoma: report of a case] [0.03%]
胰腺实性假乳头瘤合并浆液性囊腺瘤病例报告
Y S Su,W B Dai,S X Zhang et al.
Y S Su et al.
[Pulmonary epithelioid inflammatory myofibroblastic sarcoma with EML4::ALK gene fusion: report of a case] [0.03%]
肺上皮样炎性肌纤维母细胞瘤1例伴EML4-ALK基因融合变异报告
H X Bian,F Hou,Y Wang et al.
H X Bian et al.
[H3K27me3 deficient dedifferentiated liposarcoma: report of two cases] [0.03%]
H3K27me3缺乏的去分化脂肪肉瘤两例报告
J L Li,T S Ma,J T Tong et al.
J L Li et al.